Editorial Comment to Safety and efficacy of apalutamide in Japanese patients with metastatic castration‐sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo‐controlled, phase III TITAN study

Detalles Bibliográficos
Autores principales: Zang, Zhijiang, Wang, Ziting, Chiong, Edmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Editorial Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324806/
https://www.ncbi.nlm.nih.gov/pubmed/35384091
http://dx.doi.org/10.1111/iju.14891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324806/
https://www.ncbi.nlm.nih.gov/pubmed/35384091
http://dx.doi.org/10.1111/iju.14891

Ejemplares similares